Automobile Corporation of Goa Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:48 pm

Quick Insight

The Automobile Corporation of Goa Ltd presents an intriguing investment opportunity with a current share price of ₹2,098 and a market capitalization of ₹1,277 Cr. The company's P/E ratio stands at 24.7, indicating a reasonable valuation, while boasting a robust ROE of 19.7% and ROCE of 20.2%, reflecting strong profitability and efficient capital utilization. With a healthy operating profit margin of 11% and a net profit of ₹47 Cr, the company demonstrates sound financial performance. However, the lack of detailed shareholder information raises transparency concerns. Investors should consider the company's solid reserves of ₹248 Cr and manageable borrowings of ₹86 Cr. Furthermore, the impressive Interest Coverage Ratio of 745.77x enhances the company's financial stability. Overall, despite some opacity regarding ownership structure, the Automobile Corporation of Goa Ltd appears fundamentally strong and worthy of further due diligence for potential investment.

Competitors of Automobile Corporation of Goa Ltd

All Competitor Stocks of Automobile Corporation of Goa Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:00 am

Below is a detailed analysis of the quarterly data for Automobile Corporation of Goa Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 256.00 Cr.. The value appears strong and on an upward trend. It has increased from 217.00 Cr. (Mar 2025) to 256.00 Cr., marking an increase of 39.00 Cr..
• For Expenses, as of Jun 2025, the value is 229.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 197.00 Cr. (Mar 2025) to 229.00 Cr., marking an increase of 32.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 8.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 11.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 6.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 37.89. The value appears strong and on an upward trend. It has increased from 27.66 (Mar 2025) to 37.89, marking an increase of 10.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:46 pm

Balance Sheet

Last Updated: July 25, 2025, 1:47 pm

Below is a detailed analysis of the balance sheet data for Automobile Corporation of Goa Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Reserves, as of Mar 2025, the value is 248.00 Cr.. The value appears strong and on an upward trend. It has increased from 213.00 Cr. (Mar 2024) to 248.00 Cr., marking an increase of 35.00 Cr..
• For Borrowings, as of Mar 2025, the value is 86.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 63.00 Cr. (Mar 2024) to 86.00 Cr., marking an increase of 23.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 126.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 91.00 Cr. (Mar 2024) to 126.00 Cr., marking an increase of 35.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 465.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 373.00 Cr. (Mar 2024) to 465.00 Cr., marking an increase of 92.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 62.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Mar 2024) to 62.00 Cr., marking an increase of 11.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Investments, as of Mar 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 120.00 Cr., marking an increase of 120.00 Cr..
• For Other Assets, as of Mar 2025, the value is 282.00 Cr.. The value appears to be declining and may need further review. It has decreased from 321.00 Cr. (Mar 2024) to 282.00 Cr., marking a decrease of 39.00 Cr..
• For Total Assets, as of Mar 2025, the value is 465.00 Cr.. The value appears strong and on an upward trend. It has increased from 373.00 Cr. (Mar 2024) to 465.00 Cr., marking an increase of 92.00 Cr..

Notably, the Reserves (248.00 Cr.) exceed the Borrowings (86.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Automobile Corporation of Goa Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 76.54. This value is within the healthy range. It has increased from 63.02 (Mar 24) to 76.54, marking an increase of 13.52.
• For Diluted EPS (Rs.), as of Mar 25, the value is 76.54. This value is within the healthy range. It has increased from 63.02 (Mar 24) to 76.54, marking an increase of 13.52.
• For Cash EPS (Rs.), as of Mar 25, the value is 84.10. This value is within the healthy range. It has increased from 71.16 (Mar 24) to 84.10, marking an increase of 12.94.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 416.75. It has increased from 359.60 (Mar 24) to 416.75, marking an increase of 57.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 416.75. It has increased from 359.60 (Mar 24) to 416.75, marking an increase of 57.15.
• For Dividend / Share (Rs.), as of Mar 25, the value is 25.00. This value exceeds the healthy maximum of 3. It has increased from 20.00 (Mar 24) to 25.00, marking an increase of 5.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,085.25. It has increased from 959.73 (Mar 24) to 1,085.25, marking an increase of 125.52.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 110.36. This value is within the healthy range. It has increased from 92.15 (Mar 24) to 110.36, marking an increase of 18.21.
• For PBIT / Share (Rs.), as of Mar 25, the value is 102.80. This value is within the healthy range. It has increased from 84.01 (Mar 24) to 102.80, marking an increase of 18.79.
• For PBT / Share (Rs.), as of Mar 25, the value is 102.65. This value is within the healthy range. It has increased from 83.87 (Mar 24) to 102.65, marking an increase of 18.78.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 76.54. This value is within the healthy range. It has increased from 63.02 (Mar 24) to 76.54, marking an increase of 13.52.
• For PBDIT Margin (%), as of Mar 25, the value is 10.16. This value is within the healthy range. It has increased from 9.60 (Mar 24) to 10.16, marking an increase of 0.56.
• For PBIT Margin (%), as of Mar 25, the value is 9.47. This value is below the healthy minimum of 10. It has increased from 8.75 (Mar 24) to 9.47, marking an increase of 0.72.
• For PBT Margin (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 10. It has increased from 8.73 (Mar 24) to 9.45, marking an increase of 0.72.
• For Net Profit Margin (%), as of Mar 25, the value is 7.05. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 7.05, marking an increase of 0.49.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.36. This value is within the healthy range. It has increased from 17.52 (Mar 24) to 18.36, marking an increase of 0.84.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.37. This value is within the healthy range. It has increased from 22.04 (Mar 24) to 23.37, marking an increase of 1.33.
• For Return On Assets (%), as of Mar 25, the value is 10.01. This value is within the healthy range. It has decreased from 10.28 (Mar 24) to 10.01, marking a decrease of 0.27.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 0.33, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.58. It has decreased from 1.65 (Mar 24) to 1.58, marking a decrease of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 2.01. This value is within the healthy range. It has decreased from 2.21 (Mar 24) to 2.01, marking a decrease of 0.20.
• For Quick Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has decreased from 1.86 (Mar 24) to 1.73, marking a decrease of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.67. This value exceeds the healthy maximum of 8. It has increased from 8.11 (Mar 24) to 8.67, marking an increase of 0.56.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 26.12. This value is within the healthy range. It has decreased from 31.73 (Mar 24) to 26.12, marking a decrease of 5.61.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 23.78. This value is within the healthy range. It has decreased from 28.10 (Mar 24) to 23.78, marking a decrease of 4.32.
• For Earning Retention Ratio (%), as of Mar 25, the value is 73.88. This value exceeds the healthy maximum of 70. It has increased from 68.27 (Mar 24) to 73.88, marking an increase of 5.61.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 76.22. This value exceeds the healthy maximum of 70. It has increased from 71.90 (Mar 24) to 76.22, marking an increase of 4.32.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 745.77. This value is within the healthy range. It has increased from 660.84 (Mar 24) to 745.77, marking an increase of 84.93.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 518.25. This value is within the healthy range. It has increased from 452.93 (Mar 24) to 518.25, marking an increase of 65.32.
• For Enterprise Value (Cr.), as of Mar 25, the value is 786.77. It has decreased from 1,337.86 (Mar 24) to 786.77, marking a decrease of 551.09.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has decreased from 2.29 (Mar 24) to 1.19, marking a decrease of 1.10.
• For EV / EBITDA (X), as of Mar 25, the value is 11.71. This value is within the healthy range. It has decreased from 23.85 (Mar 24) to 11.71, marking a decrease of 12.14.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.17, marking a decrease of 1.08.
• For Retention Ratios (%), as of Mar 25, the value is 73.87. This value exceeds the healthy maximum of 70. It has increased from 68.26 (Mar 24) to 73.87, marking an increase of 5.61.
• For Price / BV (X), as of Mar 25, the value is 3.05. This value exceeds the healthy maximum of 3. It has decreased from 6.02 (Mar 24) to 3.05, marking a decrease of 2.97.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.17, marking a decrease of 1.08.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.06, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness